Literature DB >> 7999103

GDP-ribosyl cyclase activity as a measure of CD38 induction by retinoic acid in HL-60 cells.

R M Graeff1, K Mehta, H C Lee.   

Abstract

Retinoic acid (RA) treatment of HL-60 cells induces surface expression of CD38. This lymphocytic antigen is also a novel bifunctional enzyme catalyzing the synthesis and hydrolysis of cyclic ADP-ribose (cADPR), a Ca2+ mobilizing metabolite of NAD+. The synthetic activity of CD38 is very difficult to detect because of the concurrent hydrolytic activity. In this study, a Ca2+ release assay capable of detecting submicromolar concentrations of cADPR was used to demonstrate the induction of ADP-ribosyl cyclase activity in HL-60 cells by RA. Concomitantly, cADPR hydrolase activity was also increased. The results were further substantiated by using a newly developed assay for GDP-ribosyl cyclase activity. This assay uses NGD+ as substrate instead of NAD+. The resulting fluorescent product, cyclic GDP-ribose, is resistant to hydrolysis and accumulates, making it a highly sensitive and convenient assay for CD38-like enzymes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7999103     DOI: 10.1006/bbrc.1994.2725

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Structure and enzymatic functions of human CD38.

Authors:  Hon Cheung Lee
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

Review 2.  Structures and activities of cyclic ADP-ribose, NAADP and their metabolic enzymes.

Authors:  H C Lee; C Munshi; R Graeff
Journal:  Mol Cell Biochem       Date:  1999-03       Impact factor: 3.396

3.  Effect of estrogen upon cyclic ADP ribose metabolism: beta-estradiol stimulates ADP ribosyl cyclase in rat uterus.

Authors:  E N Chini; F G de Toledo; M A Thompson; T P Dousa
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

4.  Human CD38 is an authentic NAD(P)+ glycohydrolase.

Authors:  V Berthelier; J M Tixier; H Muller-Steffner; F Schuber; P Deterre
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

5.  ATRA-induced HL-60 myeloid leukemia cell differentiation depends on the CD38 cytosolic tail needed for membrane localization, but CD38 enzymatic activity is unnecessary.

Authors:  Johanna Congleton; Hong Jiang; Fabio Malavasi; Hening Lin; Andrew Yen
Journal:  Exp Cell Res       Date:  2010-12-13       Impact factor: 3.905

Review 6.  CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity.

Authors:  Zayda L Piedra-Quintero; Zachary Wilson; Porfirio Nava; Mireia Guerau-de-Arellano
Journal:  Front Immunol       Date:  2020-11-30       Impact factor: 7.561

7.  Transcription Factor Activation Profiles (TFAP) identify compounds promoting differentiation of Acute Myeloid Leukemia cell lines.

Authors:  Federica Riccio; Elisa Micarelli; Riccardo Secci; Giulio Giuliani; Simone Vumbaca; Giorgia Massacci; Luisa Castagnoli; Claudia Fuoco; Gianni Cesareni
Journal:  Cell Death Discov       Date:  2022-01-10

8.  A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline.

Authors:  Mariana G Tarragó; Claudia C S Chini; Karina S Kanamori; Gina M Warner; Ariel Caride; Guilherme C de Oliveira; Micaela Rud; Adrienne Samani; Kyaw Z Hein; Runqing Huang; Diana Jurk; Dong Seong Cho; James J Boslett; Jordan D Miller; Jay L Zweier; João F Passos; Jason D Doles; David J Becherer; Eduardo N Chini
Journal:  Cell Metab       Date:  2018-05-01       Impact factor: 27.287

9.  Immuno-targeting the multifunctional CD38 using nanobody.

Authors:  Ting Li; Shali Qi; Mandy Unger; Yun Nan Hou; Qi Wen Deng; Jun Liu; Connie M C Lam; Xian Wang Wang; Du Xin; Peng Zhang; Friedrich Koch-Nolte; Quan Hao; Hongmin Zhang; Hon Cheung Lee; Yong Juan Zhao
Journal:  Sci Rep       Date:  2016-06-02       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.